Assenagon Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $168M | Sell |
|
|||||
|
2025
Q2 | $142M | Buy |
|
|||||
|
2025
Q1 | $92M | Buy |
|
|||||
|
2024
Q4 | $25.6M | Sell |
|
|||||
|
2024
Q3 | $25M | Buy |
|
|||||
|
2024
Q2 | $6.57M | Sell |
|
|||||
|
2024
Q1 | $14.8M | Buy |
|
|||||
|
2023
Q4 | $6.05M | Buy |
|
|||||
|
2023
Q3 | $734K | Sell |
|
|||||
|
2023
Q2 | $13.9M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $9.45M | Buy |
|
|||||
|
2022
Q3 | $7.38M | Buy |
|
|||||
|
2022
Q2 | $4.01M | Sell |
|
|||||
|
2022
Q1 | $5.01M | Sell |
|
|||||
|
2021
Q4 | $4.27M | Buy |
|
|||||
|
2021
Q3 | $4.87M | Buy |
|